Vitadio
Healthcare AI
Digital therapeutics for diabetes and cardiometabolic diseases
Seed
Vitadio is a European **digital therapeutics** company focused on **AI-driven prescription digital therapies for type 2 diabetes and prediabetes**, delivering clinically validated, regulator-approved mobile apps that support lifestyle modification, glycemic control, and weight reduction, with its flagship therapy fully reimbursed by statutory health insurers in Germany.
Company Details
- Website
- vitad.io
- Headquarters
- Prague, Czech Republic & Berlin, Germany
- Founded
- 2019
- Funding
- €4M (~$4.4M)
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring